RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 105.00
+0.80 (0.77%)
Apr 27, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 75.51 billion as of April 27, 2026. Its market cap has increased by 252.49% in one year.
Market Cap
75.51B
Enterprise Value
75.27B
Revenue
3.62B
Ranking
n/a
PE Ratio
72.59
Stock Price
105.00
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 75.51B, an increase of 126.16%. That is a compound annual growth rate of 16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 76.50B | 69.25% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 148.88B |
| WuXi Biologics | 138.70B |
| Akeso | 121.22B |
| Sichuan Kelun-Biotech Biopharmaceutical | 115.34B |
| Sino Biopharmaceutical | 101.49B |
| 3SBio | 56.85B |
| Biocytogen Pharmaceuticals (Beijing) | 46.28B |
| Shanghai Henlius Biotech | 44.97B |